Abstract
Introduction and hypothesis
Patient-reported outcome measures (PROMs) are important for understanding the success of surgery for stress urinary incontinence, as patient perception of success does not always correlate with physician perception of success. We report PROMS after single-incision slings (SIS) and transobturator mid-urethral slings (TMUS).
Methods
This was a planned outcome analysis of secondary endpoints in a study in which the primary aim was to compare efficiency and safety using a non-inferiority design (results reported previously). In this analysis of quality of life (QOL), validated PROMs were collected at baseline, 6, 12, 18, 24, and 36 months to quantify incontinence severity (Incontinence Severity Index), symptom bother (Urogenital Distress Inventory), disease-specific QOL impact (Urinary Impact Questionnaire), and generic QOL impact (PGI-I; not applicable at baseline). PROMs were analyzed within treatment groups as well as between groups. Propensity score methods were used to adjust for baseline differences between groups.
Results
A total of 281 subjects underwent the study procedure (141 SIS, 140 TMUS). Baseline characteristics were balanced after propensity score stratification. Participants had significant improvement in incontinence severity, disease-specific symptom bother, and QOL impact. Improvements persisted through the study and PROMs were similar between treatment groups in all assessment at 36 months
Conclusions
Following SIS and TMUS, patients with stress urinary incontinence had significant improvement in PROMs including Urogenital Distress Inventory, Incontinence Severity Index, and Urinary Impact Questionnaire at 36 months, indicating disease-specific QOL improvement. Patients have a more positive impression of change in stress urinary incontinence symptoms at each follow-up visit, indicating generic QOL improvement.
Similar content being viewed by others
References
Patel UJ, Godecker AL, Giles DL, Brown HW. Updated prevalence of urinary incontinence in women: 2015–2018 National Population-Based Survey Data. Female Pelvic Med Reconstr Surg. 2022;28(4):181–7; https://doi.org/10.1097/spv.0000000000001127.
Wu JM, Matthews CA, Conover MM, Pate V, Jonsson FM. Lifetime risk of stress urinary incontinence or pelvic organ prolapse surgery. Obstet Gynecol. 2014;123(6):1201–6. https://doi.org/10.1097/aog.0000000000000286.
Rickey LM, Casilla-Lennon M. Prevention of stress urinary incontinence in women. Curr Bladder Dysfunct Rep. 2020;15(1):30–7. https://doi.org/10.1007/s11884-019-00570-3.
Bemelmans BL, Chapple CR. Are slings now the gold standard treatment for the management of female urinary stress incontinence and if so which technique? Curr Opin Urol. 2003;13(4):301–7. https://doi.org/10.1097/00042307-200307000-00006.
Kobashi KC, Albo ME, Dmochowski RR, et al. Surgical treatment of female stress urinary incontinence: AUA/SUFU guideline. J Urol 2017;198(4):875–83.
Madsen AM, El-Nashar SA, Woelk JL, Klingele CJ, Gebhart JB, Trabuco EC. A cohort study comparing a single-incision sling with a retropubic midurethral sling. Int Urogynecol J. 2014;25(3):351–8. https://doi.org/10.1007/s00192-013-2208-6.
Ford AA, Ogah JA. Retropubic or transobturator mid-urethral slings for intrinsic sphincter deficiency-related stress urinary incontinence in women: a systematic review and meta-analysis. Int Urogynecol J. 2016;27(1):19–28. https://doi.org/10.1007/s00192-015-2797-3.
Jiao B, Lai S, Xu X, Zhang M, Diao T, Zhang G. A systematic review and meta-analysis of single-incision mini-slings (MiniArc) versus transobturator mid-urethral slings in surgical management of female stress urinary incontinence. Medicine (Baltimore). 2018;97(14):e0283. https://doi.org/10.1097/md.0000000000010283.
Abdel-Fattah M, Ford JA, Lim CP, Madhuvrata P. Single-incision mini-slings versus standard midurethral slings in surgical management of female stress urinary incontinence: a meta-analysis of effectiveness and complications. Eur Urol. 2011;60(3):468–80. https://doi.org/10.1016/j.eururo.2011.05.003.
Schellart RP, Oude Rengerink K, Van der Aa F, et al. A randomized comparison of a single-incision midurethral sling and a transobturator midurethral sling in women with stress urinary incontinence: results of 12-mo follow-up. Eur Urol. 2014;66(6):1179–85. https://doi.org/10.1016/j.eururo.2014.07.027.
Hota LS, Hanaway K, Hacker MR, et al. TVT-Secur (Hammock) versus TVT-Obturator: a randomized trial of suburethral sling operative procedures. Female Pelvic Med Reconstr Surg. 2012;18(1):41–5. https://doi.org/10.1097/SPV.0b013e31823bdbcf.
Nambiar A, Cody JD, Jeffery ST, Aluko P. Single-incision sling operations for urinary incontinence in women. Cochrane Database Syst Rev. 2017;7(7):CD008709. https://doi.org/10.1002/14651858.CD008709.pub3.
Centers for Medicare and Medicaid Services (CMS). Patient Reported Outcome Measures. https://www.cms.gov/files/document/blueprint-patient-reported-outcome-measures.pdf. Published September 2021. Accessed 9 March 2022.
U.S. Food & Drug Administration (FDA). Guidance Document: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/patient-reported-outcome-measures-use-medical-product-development-support-labeling-claims. Published December 2009. Accessed 9 March 2022.
Saraswat L, Rehman H, Omar MI, Cody JD, Aluko P, Glazener CM. Traditional suburethral sling operations for urinary incontinence in women. Cochrane Database Syst Rev. 2020;1(1):CD001754 https://doi.org/10.1002/14651858.CD001754.pub5.
Abdel-Fattah M, Cooper D, Davidson T, et al. Single-incision mini-slings for stress urinary incontinence in women. N Engl J Med. 2022;386(13):1230–43. https://doi.org/10.1056/NEJMoa2111815.
White AB, Kahn BS, Gonzalez RR, et al. Prospective study of a single-incision sling versus a transobturator sling in women with stress urinary incontinence: 3-year results. Am J Obstet Gynecol. 2020;223(4):545.e1–545.e11. https://doi.org/10.1016/j.ajog.2020.03.008.
White AB, Anger JT, Eilber K, Kahn BS, Gonzalez RR, Rosamilia A. Female sexual function following sling surgery: a prospective parallel cohort, multi-center study of the Solyx™ single incision sling system versus the Obtryx™ II sling system. J Urol. 2021;206(3):696–705. https://doi.org/10.1097/ju.0000000000001830.
Uebersax JS, Wyman JF, Shumaker SA, McClish DK, Fantl JA. Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program for Women Research Group. Neurourol Urodyn. 1995;14(2):131–9. https://doi.org/10.1002/nau.1930140206.
Sandvik H, Seim A, Vanvik A, Hunskaar S. A severity index for epidemiological surveys of female urinary incontinence: comparison with 48-hour pad-weighing tests. Neurourol Urodyn. 2000;19(2):137–45. https://doi.org/10.1002/(sici)1520-6777(2000)19:2<137::aid-nau4>3.0.co;2-g.
Barber MD, Walters MD, Bump RC. Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7). Am J Obstet Gynecol 2005;193(1):103-13. https://doi.org/10.1016/j.ajog.2004.12.025
Yalcin I, Bump RC. Validation of two global impression questionnaires for incontinence. Am J Obstet Gynecol. 2003;189(1):98–101. https://doi.org/10.1067/mob.2003.379.
Barber MD, Spino C, Janz NK, et al. The minimum important differences for the urinary scales of the Pelvic Floor Distress Inventory and Pelvic Floor Impact Questionnaire. Am J Obstet Gynecol. 2009;200(5):580.e1–7. https://doi.org/10.1016/j.ajog.2009.02.007.
Rubin DB. Using propensity scores to help design observational studies: application to the tobacco litigation. Health Serv Outcomes Res Methodol. 2001;2(3):169–88. https://doi.org/10.1023/A:1020363010465.
Yue LQ, Lu N, Xu Y. Designing premarket observational comparative studies using existing data as controls: challenges and opportunities. J Biopharm Stat. 2014;24(5):994–1010. https://doi.org/10.1080/10543406.2014.926367.
Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003;41(5):582–92. https://doi.org/10.1097/01.Mlr.0000062554.74615.4c.
Golbasi C, Taner CE, Golbasi H. Long-term outcomes and quality of life effects of single incision mini sling procedure in stress urinary incontinence patients. Eur J Obstet Gynecol Reprod Biol. 2019;234:10–3. https://doi.org/10.1016/j.ejogrb.2018.12.030.
Barber MD, Weidner AC, Sokol AI, et al. Single-incision mini-sling compared with tension-free vaginal tape for the treatment of stress urinary incontinence: a randomized controlled trial. Obstet Gynecol. 2012;119(2 Pt 1):328–37. https://doi.org/10.1097/AOG.0b013e318242a849.
Frigerio M, Milani R, Barba M, et al. Single-incision slings for the treatment of stress urinary incontinence: efficacy and adverse effects at 10-year follow-up. Int Urogynecol J. 2021;32(1):187–91. https://doi.org/10.1007/s00192-020-04499-8.
Barber MD, Brubaker L, Nygaard I, et al. Defining success after surgery for pelvic organ prolapse. Obstet Gynecol. 2009;114(3):600–9. https://doi.org/10.1097/AOG.0b013e3181b2b1ae.
Jelovsek JE, Gantz MG, Lukacz E, et al. Success and failure are dynamic, recurrent event states after surgical treatment for pelvic organ prolapse. Am J Obstet Gynecol. 2021;224(4):362.e1. https://doi.org/10.1016/j.ajog.2020.10.009.
Mostafa A, Lim CP, Hopper L, Madhuvrata P, Abdel-Fattah M. Single-incision mini-slings versus standard midurethral slings in surgical management of female stress urinary incontinence: an updated systematic review and meta-analysis of effectiveness and complications. Eur Urol. 2014;65(2):402–27. https://doi.org/10.1016/j.eururo.2013.08.032.
Loganathan J, Coffey J, Doumouchtsis SK. Which patient reported outcomes (PROs) and patient reported outcome measures (PROMs) do researchers select in stress urinary incontinence surgical trials?—A systematic review. Int Urogynecol J. 2022;33(11):2941–9. https://doi.org/10.1007/s00192-022-05123-7.
Acknowledgements
We acknowledge Guang Yang and Dongfeng Qi at Boston Scientific for their contributions to the statistical analysis and Kristen Griffin at Boston Scientific for editing support. We also thank the participating study sites and investigators: Scott R. Serels, Norwalk Urology Associates, Norwalk, CT, USA; Sam Siddighi, Loma Linda University, Loma Linda, CA, USA; Pill Raja, Permian Research Foundation, Odessa, TX, USA; Thomas Hutchens, Mid Dakota Clinic, Bismarck, ND, USA; Barry Jarnagin, Center for Pelvic Health, Franklin, TN, USA; Amanda White, University of Texas at Austin Dell Medical School, Austin, TX, USA; Michael Litrel, Cherokee Women’s Health Specialists, Canton, GA, USA; Ricardo Gonzalez, Houston Methodist, Houston, TX, USA; Bradley Jacobs, Lyndhurst Clinical Research, Winston Salem, NC, USA; Kaiser Robertson III, Chesapeake Urology Research Associates, Hanover, MD, USA; Karyn Eilber, Cedars-Sinai Medical Center, Beverly Hills, CA, USA; Michael England, Baylor University Medical Center, Fort Worth, TX, USA; Bruce Kahn, Scripps Clinic, San Diego, CA, USA; William Porter, Novant Health Presbyterian Medical Center, Charlotte, NC, USA; Joseph Gauta, The Florida Bladder Institute, Naples, FL, USA; Kyle P. McMorries/Mitchell Silver, Nacogdoches, TX, USA; Howard Goldstein, Christiana Care, Newark, DE, USA; James Rice, Multicare Women’s Center, Covington, WA, USA; John Zavaleta, Las Colinas ObGyn, Irving, TX, USA; Jeff Livingston, MacArthur Ob/Gyn Management, Irving, TX, USA; and Anna Rosamilia, Monash Medical Centre and Cabrini Hospital, Melbourne, Australia.
Author information
Authors and Affiliations
Contributions
R.R.G.: manuscript writing/editing, project development; A.R.: recruitment/manuscript writing and editing; K.E.: manuscript writing/editing; B.S.K.: manuscript writing/editing, data analysis; A.B.W.: manuscript writing/editing; J.T.A.: manuscript writing/editing.
Corresponding author
Ethics declarations
Financial disclaimers/conflicts of interest
R.R.G.: Boston Scientific (consultant, investigator); A.R.: Boston Scientific (investigator), Glycolyx Inc (consultant), International Continence Society (ICS) (co-scientific Chair, 2021); K.E.: Coloplast (consultant), Boston Scientific (investigator); B.S.K.: Boston Scientific (investigator), Solaire (investigator), Ark Surgical (consultant); A.B.W.: Boston Scientific (consultant).
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
ESM 1
(DOCX 52 kb)
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Gonzalez, R.R., Rosamilia, A., Eilber, K. et al. Three-year patient-reported outcomes of single-incision versus transobturator slings for female stress urinary incontinence are equivalent. Int Urogynecol J 34, 2265–2274 (2023). https://doi.org/10.1007/s00192-023-05538-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00192-023-05538-w